• 1
    Cushing H: The basophil adenomas of the pituitary and their clinical manifestations. Bull Hopkins Hosp 50: 137195, 1932
  • 2
    Kleerekoper M, Rao DS, Matovic V, Whyte MP, Avioli LV: Endogenous Cushing's disease in two adults presenting with osteopenia as the major clinical manifestation, Osteoporosis. Vol. 2. Edited by US Barzell. New York, Grune and Stratton, 1979
  • 3
    Hench PS, Kendall EC, Slocumb CH, Polley HF: Effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Mayo Clin Proc 24: 181197, 1949
  • 4
    Boland EW, Headley NE: Management of rheumatoid arthritis with smaller (maintenance) doses of cortisone acetate. JAMA 144: 365372, 1950
  • 5
    Kennedy AC, Smith DA, Anton HC, Buchanan WW: Generalised and localised bone loss in patients with rheumatoid arthritis. Scand J Rheumatol 4: 209215, 1975
  • 6
    Duncan H, Frost HM, Villanueva AR, Sigler JW: The osteoporosis of rheumatoid arthritis. Arthritis Rheum 8: 943954. 1965
  • 7
    Hooyman JR, Melton LJ III, Nelson AM, O'Fallon WM, Riggs BL: Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 27: 13531361, 1984
  • 8
    Saville PD, Kharmosh O: Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum 10: 423430, 1967
  • 9
    Hajiroussou VJ, Webley M: Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis 43: 2427, 1984
  • 10
    Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S: Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 30: 721728, 1987
  • 11
    Devogelaer JP, Huaux JP, Dufour JP, Esselinckx W, Stasse P, de Deuxchaisnes C Nagant: Bone-sparing action of deflazacort versus equipotent doses of prednisolone: a double-blind study in males with rheumatoid arthritis, Osteoporosis 1987. Edited by C Christiansen, JS Johansen, BJ Riis. Copenhagen, Osteopress, 1987
  • 12
    Laan RFJM, van Riel PLCM, van Erning LJThO, Lemmens JAM, Ruijs SHJ, van de Putte LBA: Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisolone therapy. Br J Rheumatol 31: 9196, 1992
  • 13
    de Deuxchaisnes C Nagant, Devogelaer JP, Esselinckx W, Bouchez B, Depresseux G, Rombouts-Lindemans C, Huaux JP: The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross sectional and a longitudinal study using single photon absorptiometry. Adv Exp Med Biol 171: 209239, 1984
  • 14
    Butler RC, Davie MWJ, Worsfold M, Sharp CA: Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Br J Rheumatol 30: 8690, 1991
  • 15
    Reid DM, Kennedy NSJ, Smith MA, Tothill P, Nuki G: Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. BMJ 285: 330332, 1982
  • 16
    Wahner HW, Dunn WL, Brown ML, Morin RL, Riggs BL: Comparison of dual-energy X-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine. Mayo Clin Proc 63: 10751084, 1988
  • 17
    Mazess R, Collick B, Trempe J, Barden H, Hanson J: Performance evaluation of a dual-energy X-ray bone densitometer. Calcif Tissue Int 44: 228232, 1989
  • 18
    Genant HK, Block JE, Steiger P, Glueer CC, Ettinger B, Harris ST: Appropriate use of bone densitometry. Radiology 170: 817822, 1989
  • 19
    Schaadt O, Bohr H: Bone mineral in lumbar spine, femoral neck and femoral shaft measured by dual photon absorptiometry with 153-Gadolinium in prednisone treatment. Adv Exp Med Biol 171: 201208, 1984
  • 20
    Ruegsegger P, Medici TC, Anliker M: Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25: 615620, 1983
  • 21
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 22
    Kirwan JR, Reeback JS: Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25: 206209, 1986
  • 23
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan W Watson: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393406, 1968
  • 24
    Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949
  • 25
    Lanham SA, Reid DM: Weight is a predictor of spine and hip bone mineral density in normal men and women, Osteoporosis 1990. Edited by C Christiansen, K Overgaard. Copenhagen, Osteopress, 1990
  • 26
    Als OS, Gotfredsen A, Riis BJ, Christiansen C: Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?. Ann Rheum Dis 44: 406411, 1985
  • 27
    Magaro M, Tricerri A, Piane D, Zoli A, Serra F, Altomonte L, Mirone L: Generalised osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatol Int 11: 7376, 1991
  • 28
    Fogelman I: Rheumatoid arthritis and osteoporosis. Br J Rheumatol 25: 240241, 1986
  • 29
    Slosman DO, Rizzoli R, Donath A, Bonjour JPh: Vertebral bone mineral density measured laterally by dual energy X-ray absorptiometry. Osteoporosis Int 1: 2329, 1990